We have already reported that shRNA-mediated knockdown of PSMD3 had no effect on survival or apoptosis of normal cord blood CD34+ progenitor cells, but reduced survival and increased apoptosis of CML cell lines in vitro and in vivo [21]. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.